Actively Recruiting
High-Sensitivity Troponin T Plasma Levels in Patients With Aortic Stenosis (Tyrolean Aortic Stenosis Study-2)
Led by Medical University Innsbruck · Updated on 2024-08-01
10000
Participants Needed
1
Research Sites
539 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
TASS-2 (Tyrolean Aortic Stenosis Study-2) aims to characterize the clinical value of minimally elevated troponin T plasma levels both in patients with asymptomatic and symtomatic aortic stenosis.
CONDITIONS
Official Title
High-Sensitivity Troponin T Plasma Levels in Patients With Aortic Stenosis (Tyrolean Aortic Stenosis Study-2)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Aortic stenosis detected by echocardiography or invasive methods
You will not qualify if you...
- Acute coronary syndrome
- Endocarditis
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Medical University Innsbruck
Innsbruck, Tyrol, Austria, 6020
Actively Recruiting
Research Team
W
Wolfgang Dichtl, MD, PhD
CONTACT
F
Fabian Barbieri
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here